(Q64607920)
Statements
RIALTO (English)
0 references
An Open-Label, Multi-center, Expanded Access Protocol of Blinatumomab for the Treatment of Pediatric and Adolescent Subjects With Relapsed and/or Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) (English)
0 references
17 year
0 references